Fundraising Fox
Immunoscape
Singapore, SG · Founded 2016 · 22 employees on LinkedIn · 1 known investors
Find your way into Immunoscape
Sign up to find every way you can get introduced to Immunoscape
- Your email: who you already know at Immunoscape, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Immunoscape team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
ImmunoScape is a Singapore-based biotechnology company developing high-throughput immune profiling and therapeutic T cell receptor discovery platforms for immunotherapy and cancer treatment. The company was spun off from Singapore's A*STAR research institute and serves the immunotherapy and oncology sectors.
Founders & leadership
Immunoscape was founded in 2016 by Michael Fehlings, PhD, Evan Newell, PhD, and Alessandra Nardin, DVM.
MF
Michael Fehlings, PhDCo-founder, Chief Executive Officer
EN
Evan Newell, PhDCo-founder/Advisor
AN
Alessandra Nardin, DVMCo-founder, Vice President Strategy
Investors · 1
Anzu Partnerslisted by Anzu PartnersBillerica
How we know: Anzu Partners's portfolio page · a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Immunoscape do?
- ImmunoScape is a Singapore-based biotechnology company developing high-throughput immune profiling and therapeutic T cell receptor discovery platforms for immunotherapy and cancer treatment. The company was spun off from Singapore's A*STAR research institute and serves the immunotherapy and oncology sectors.
- Who founded Immunoscape?
- Immunoscape was founded by Michael Fehlings, PhD, Evan Newell, PhD, Alessandra Nardin, DVM in 2016.
- Who are Immunoscape's investors?
- Immunoscape's investors include Anzu Partners.
- Where is Immunoscape headquartered?
- Immunoscape is headquartered in Singapore, SG.